会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 92. 发明授权
    • Glutathione s-transferase
    • 谷胱甘肽转移酶
    • US5976528A
    • 1999-11-02
    • US96571
    • 1998-06-12
    • Surya K. GoliJennifer L. Hillman
    • Surya K. GoliJennifer L. Hillman
    • A61K38/00A61P35/00C12N9/10C12N15/54A61K38/45
    • C12N9/1088A61K38/00Y10S424/809Y10S530/866
    • The present invention provides a human glutathione S-transferase (HGST) and polynucleotides which identify and encode HGST. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HGST and a method for producing HGST. The invention also provides for agonists, antibodies, or antagonists specifically binding HGST, and their use, in the prevention and treatment of cancer and other diseases associated with the expression of HGST. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HGST for the treatment of cancer and other diseases associated with the expression of HGST. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HGST.
    • 本发明提供了人谷胱甘肽S-转移酶(HGST)和识别和编码HGST的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码HGST的核酸序列和生产HGST的方法。 本发明还提供了特异性结合HGST的激动剂,抗体或拮抗剂及其在预防和治疗与HGST表达相关的癌症和其它疾病中的用途。 另外,本发明提供反义分子用于编码HGST的多核苷酸用于治疗与HGST表达相关的癌症和其它疾病。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合HGST的抗体的诊断测定法。
    • 94. 发明授权
    • Human C-type lectin
    • 人类C型凝集素
    • US5871964A
    • 1999-02-16
    • US688342
    • 1996-07-30
    • Janice Au-YoungBenjamin Graeme CocksSurya K. GoliJennifer L. Hillman
    • Janice Au-YoungBenjamin Graeme CocksSurya K. GoliJennifer L. Hillman
    • A61K38/00C07K14/47C12N15/54C12N15/00
    • C07K14/4726A61K38/00
    • The present invention provides a polynucleotide (mctl) which identifies and encodes a novel human C-type lectin (MCTL). The invention provides for genetically engineered expression vectors and host cells comprising the nucleic acid sequence encoding MCTL. The invention also provides for the use of substantially purified MCTL and its agonists in the commercial production of recombinant proteins and in pharmaceutical compositions for the treatment of diseases associated with the expression of MCTL. Additionally, the invention provides for the use of antisense molecules to mctl in pharmaceutical compositions for treatment of diseases associated with the expression of MCTL. The invention also describes diagnostic assays which utilize diagnostic compositions comprising the polynucleotide, fragments or the complement thereof, which hybridize with the genomic sequence or the transcript of mctl. The present invention also relates to anti-MCTL antibodies which specifically bind to MCTL.
    • 本发明提供鉴定和编码新型人C型凝集素(MCTL)的多核苷酸(mct1)。 本发明提供了包含编码MCTL的核酸序列的遗传工程表达载体和宿主细胞。 本发明还提供了在商业生产重组蛋白质和用于治疗与MCTL表达相关的疾病的药物组合物中使用基本上纯化的MCTL及其激动剂。 另外,本发明提供了用于治疗与MCTL表达相关的疾病的药物组合物中的mct1的反义分子的用途。 本发明还描述了使用包含与mct1的基因组序列或转录物杂交的多核苷酸,其片段或其互补体的诊断组合物的诊断测定法。 本发明还涉及特异性结合MCTL的抗MCTL抗体。
    • 95. 发明授权
    • Human lim proteins
    • 人体蛋白质
    • US5863898A
    • 1999-01-26
    • US739485
    • 1996-10-28
    • Surya K. GoliJennifer L. HillmanOlga Bandman
    • Surya K. GoliJennifer L. HillmanOlga Bandman
    • A61K38/00C07K14/47C07K14/00
    • C07K14/47A61K38/00
    • The present invention provides three human LIM proteins (designated individually as HLIM-1, HLIM-2, and HLIM-3, and collectively as HLIM) and polynucleotides which identify and encode HLIM. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HLIM and a method for producing HLIM. The invention also provides for use of HLIM and agonists, antibodies, or antagonists specifically binding HLIM, in the prevention and treatment of diseases associated with expression of HLIM. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HLIM for the treatment of diseases associated with the expression of HLIM. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HLIM.
    • 本发明提供了三种人LIM蛋白(分别命名为HLIM-1,HLIM-2和HLIM-3,并且共同称为HLIM)和鉴定和编码HLIM的多核苷酸。 本发明还提供了遗传工程改造的表达载体和包含编码HLIM的核酸序列的宿主细胞和生产HLIM的方法。 本发明还提供了用于预防和治疗与HLIM表达相关的疾病的HLIM和特异性结合HLIM的激动剂,抗体或拮抗剂。 另外,本发明提供反义分子用于编码HLIM的多核苷酸用于治疗与HLIM表达相关的疾病。 本发明还提供了利用多核苷酸或其片段或其补体以及特异性结合HLIM的抗体的诊断测定法。
    • 100. 发明授权
    • Human carbonyl reductase
    • 人羰基还原酶
    • US5756299A
    • 1998-05-26
    • US762129
    • 1996-12-09
    • Jennifer L. HillmanSurya K. Goli
    • Jennifer L. HillmanSurya K. Goli
    • A61K38/00C12N9/04C12N15/53C12Q1/68
    • C12N9/0006A61K38/00
    • The present invention provides a human carbonyl reductase (HCRD) and polynucleotides which identify and encode HCRD. The invention also provides genetically engineered expression vectors and host cells comprising the nucleic acid sequences encoding HCRD and a method for producing HCRD. The invention also provides for agonists, antibodies, or antagonists specifically binding HCRD, and their use, in the prevention and treatment of diseases associated with expression of HCRD. Additionally, the invention provides for the use of antisense molecules to polynucleotides encoding HCRD for the treatment of diseases associated with the expression of HCRD. The invention also provides diagnostic assays which utilize the polynucleotide, or fragments or the complement thereof, and antibodies specifically binding HCRD.
    • 本发明提供了人羰基还原酶(HCRD)和识别和编码HCRD的多核苷酸。 本发明还提供了遗传工程改造的表达载体和宿主细胞,其包含编码HCRD的核酸序列和生产HCRD的方法。 本发明还提供了特异性结合HCRD的激动剂,抗体或拮抗剂及其在预防和治疗与HCRD表达相关的疾病中的用途。 另外,本发明提供了反义分子用于编码HCRD的多核苷酸用于治疗与HCRD表达有关的疾病的用途。 本发明还提供利用多核苷酸或其片段或其补体以及特异性结合HCRD的抗体的诊断测定法。